WallStreetZenWallStreetZen

How to Buy Humacyte Stock

Humacyte Inc

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

Humacyte stock last closed at $3.90, up 2.09% from the previous day, and has increased 15.04% in one year. It has overperformed other stocks in the Biotechnology industry by 0.39 percentage points. Humacyte stock is currently +98.98% from its 52-week low of $1.96, and -30.36% from its 52-week high of $5.60.

There are currently 119.08M shares of HUMA outstanding. The market cap of HUMA is $464.43M. In the past 24 hours, 789,562 HUMA shares were traded.

How to Buy Humacyte Stock

Not sure how to invest in Humacyte stock? Here's how.
  1. Decide where to buy Humacyte stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you determine where to buy Humacyte stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit funds into your investment account: Pick your method of payment and add your information.
  4. Research Humacyte stock: The Humacyte ticker symbol is HUMA. Is Humacyte stock a good investment? Should you buy shares of HUMA? How do HUMA's underlying business fundamentals look? Do top analysts think Humacyte is a good buy? Why has HUMA's stock price moved recently? (Hint: Our stock market research website can help you figure out if HUMA is a good stock to buy).
  5. Make your HUMA trade: Decide if you will purchase HUMA shares at the current market price or use a limit order to purchase HUMA shares at a given price.
  6. Get key alerts regarding your investment in HUMA: Create a watchlist to keep tabs on your new investment in Humacyte stock.

Step 1: Decide where to buy Humacyte stock

You need a brokerage account in order to access the NASDAQ market and buy HUMA shares.

A brokerage account allows you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Technology to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the world's top stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of stock by signing up for an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've chosen the best brokerage, you'll need to fill out some personal details so you can buy HUMA today.

How to Create a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal info to create your new trading account.
  1. Submit your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have created your account on the highest rated app to buy and sell stocks, your next step is to transfer the money for your investment:

Watch this video walkthrough to see the process of transferring money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Humacyte stock

Once you have decided on the best place to buy Humacyte stock, it's important to analyze their stock prior to buying, so you actually understand the risk and opportunity.

Humacyte Metrics

HUMA Price
$3.90
1w %
8.64%
1y %
15.04%
5y %
N/A
P/E
-3.64x
P/B
34.29x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$110.78M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$464.43M
Next Earnings
May 10, 2024
Next Dividend
N/A

Humacyte Zen Score

WallStreetZen was designed to help everyday investors perform better fundamental analysis in minutes instead of hours.

You can view all of the due diligence checks on HUMA's stock page.

How is HUMA stock valued?

Investors use many financial metrics, analyses, models, and charts to gauge HUMA's fair value.

Using relative valuations ratios:

  • HUMA could be overvalued based on its P/B ratio of 34.29x, relative to Biotechnology industry P/B ratio of 5.8x

You can do additional valuation research on HUMA's stock here.

A quick look at HUMA Financials

Signs that HUMA is financially healthy:

  • HUMA has cash burn of 75585000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the HUMA balance sheet.

Signs that HUMA is not financially healthy:

  • HUMA has $80.45M in cash and short term investments. This is not sufficient to cover its annual cash burn of $75.59M.
  • HUMA has a relatively high debt to equity ratio of 8.47.
  • There are more long-term liabilities than short-term assets on the HUMA balance sheet.

Is Humacyte stock a Buy, Hold, or Sell, according to Wall Street analysts?

Out of 5 Wall Street analysts who give forecasts on HUMA, the consensus analyst rating on Humacyte is a Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.

You can dive deeper into what analysts are saying on the Humacyte stock forecast page.

Metrics for Advanced HUMA Traders

SMA10
3.46
SMA20
3.25
SMA50
3.53
SMA100
3.24
SMA200
3.1
MACD
0.13
MACD Signal
0.01
MACD Histogram
0.12
RSI
66.03
Stochastic %K
78.06
Stochastic %D
75.1
StochRSI %K
92.47
StochRSI %D
95.93

HUMA Growth Metrics

Last year, HUMA revenue was $0.00. Over the past 4 year, HUMA's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 28.62%.

Find out more about HUMA's earnings and revenue performance here.

Are HUMA executives and large shareholders buying or selling the stock?

Over the past 12 months, insiders at HUMA have sold more shares than they have bought.

Max N. Wallace, Director of HUMA, was the latest HUMA insider to buy. They bought $7,811.16 worth of HUMA shares on Nov 21, 2023.

Research more about who owns HUMA shares here.

Does HUMA stock generate passive income?

No, Humacyte doesn't provide an income stream by paying out dividends.

What others are saying about HUMA

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Make your HUMA trade

You have two primary options:

  • Market order: A market order is an order to buy or sell a stock at the best possible price.
    Market orders are generally fine for most investors.
  • Limit order: A limit order lets you buy or sell a stock at a specific price (or better).
    If you want to ensure you're buying or selling at an exact dollar amount limit, place a limit order.

Hit the Open button and your broker will execute the order.

If you want additional assistance buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get key alerts regarding your investment in HUMA

Now that you own some shares in HUMA, you'll want to stay up-to-date on your new investment.

Make a watchlist to monitor your HUMA stock.

HUMA Feed

How to Buy Stock in Humacyte

To summarize, here are the 6 steps to buy Humacyte stock:

  1. Decide where to buy Humacyte stock
  2. Open a brokerage account
  3. Deposit funds into your investment account
  4. Research Humacyte stock
  5. Make your HUMA trade
  6. Get key alerts regarding your investment in HUMA

If you need a online brokerage, eToro is our favorite venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get notifications regarding your new investment in Humacyte, click below.

NASDAQ: HUMA
$3.90+0.08 (+2.09%)
Updated Apr 25, 2024
Open eToro Account
NASDAQ: HUMA
$3.90+0.08 (+2.09%)
Updated Apr 25, 2024
Open eToro Account

FAQ

How much does it cost to buy one Humacyte share?

As of Apr 25, 2024, it costs $3.90 to buy one share of Humacyte stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.256 shares of HUMA.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Humacyte stock?

According to 5 Wall Street analysts who monitor Humacyte, their consensus recommendation is to buy Humacyte stock.

What is the best way to buy Humacyte stock?

One way to place an order for Humacyte stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.